Skip to main content

Advertisement

SpringerLink
Log in

The role of anticonvulsants in preventive migraine therapy

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The mainstay of migraine treatment is pharmacotherapy. There have been numerous medications used to prevent migraine headaches, including β-blockers, calcium-channel blockers, anticonvulsants, and nonsteroidal anti-inflammatory drugs. Sodium valproate is the only antiepileptic drug approved by the Food and Drug Administration for migraine prevention. Newer antiepileptics, including gabapentin and topiramate, are being evaluated for their role in preventive therapy. The mechanism of action of antiepileptics is not fully understood, but they all share a common role in enhancing gamma-aminobutyric acid-mediated inhibition. This article reviews the role of anticonvulsants in preventive migraine therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lipton RB, Stewart WF, Diamond S, et al.: Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001, 41:646–657.

    Article  PubMed  CAS  Google Scholar 

  2. Collins JG: Prevalence of selected chronic conditions in the United States. Vital Health Statistics 1986, 10:1–66.

    Google Scholar 

  3. Ramadan NM, Silberstein SD, Freitag FG, et al.: Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management for Prevention of Migraine. Neurology (serial online). http://www.neurology. org. Accessed on August 12, 2002. A superb review of the clinical trials of preventives of migraine headaches.

  4. Morey SS: Guidelines of migraine, part 4: general principles of preventive therapy. Am Fam Physician 2000, 62:2359–2363.

    PubMed  CAS  Google Scholar 

  5. Koehler PJ, Bruyn GW: Migraine treatment in the Netherlands in the early 20th century. Ned Tijdschr Geneeskd 1988, 142:2009–2013.

    Google Scholar 

  6. Depakote ER: Migraine study group: a randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002, 58:1652–1659.

    Google Scholar 

  7. Loscher W: Valproate induced changes in GABA metabolism at the subcellular level. Bichem Pharmacol 1981, 30:1364–1366.

    Article  CAS  Google Scholar 

  8. Bloom FE: Neurohumoral transmission and the central nervous system. In Goodman and Gilman’s The Pharmacological Basis of Therapeutics, edn 8. Edited by Gilman AG, Rall TW, Nies AS, Taylor P. New York: McGraw-Hill; 1990:244–268.

    Google Scholar 

  9. Cutrer FM, Silberstein SD, Mathew NT, Rozen TD: Antiepileptic drugs in migraine, cluster headache, and mood disorders. Headache 2001, 41(suppl 1):S1-S32. A thorough review of the pathophysiology of migraine headaches and the mechanism of action of various antiepileptic drugs.

    Article  Google Scholar 

  10. Magnus L: Nonepileptic uses of gabapentin. Epilepsia 1999, 40(suppl 6):566–572.

    Google Scholar 

  11. Cutrer FM: Antiepileptic drugs: how they work in headache. Headache 2001, 41(suppl 1):S3-S10.

    Article  PubMed  Google Scholar 

  12. Mathew NT: Antiepileptic drugs in migraine prevention. Headache 2001, 41(suppl 1):518–524.

    Google Scholar 

  13. Sorenson KV: Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand 1988, 78:346–348.

    Article  Google Scholar 

  14. Hering R, Kuritzky A: Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992, 12:81–84.

    Article  PubMed  CAS  Google Scholar 

  15. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebocontrolled crossover study. Neurology 1994, 44:647–651.

    PubMed  CAS  Google Scholar 

  16. Mathew NT, Saper JR, Silberstein SD, et al.: Migraine prophylaxis with divalproex. Arch Neurol 1995, 52:281–286.

    PubMed  CAS  Google Scholar 

  17. Klapper J: Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997, 17:103–108.

    Article  PubMed  CAS  Google Scholar 

  18. Kinze S, Clauss M, Reuter U, et al.: Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open-label study. Headache 2001, 41:774–778.

    Article  PubMed  CAS  Google Scholar 

  19. Tfelt-Hansen P: Prophylactic pharmacotherapy of migraine: some practical guidelines. Neurol Clin 1997, 15:153–165.

    Article  PubMed  CAS  Google Scholar 

  20. Silberstein SD, Collins SD: Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Longterm Safety of Depakote in Headache Prophylaxis Study Group. Headache 1999, 39:633–643.

    Article  PubMed  CAS  Google Scholar 

  21. Rompel H, Bauermeister PW: Etiology of migraine and prevention with carbamazepine (Tegretol): results of a doubleblind, cross-over study. S Afr Med J 1970, 44:75–80.

    PubMed  CAS  Google Scholar 

  22. Stensrud P, Sjaastad O: Clonazepam (rivotril) in migraine prophylaxis. Headache 1979, 19:333–334.

    Article  PubMed  CAS  Google Scholar 

  23. Wessely P, Baumgarrtner C, Klingler D, et al.: Preliminary results of a double-blind study with the new migraine prophylactic drug Gabapentin. Cephalalgia 1987, 7(suppl 6):477–478.

    Google Scholar 

  24. Mathew NT, Rapoport A, Saper J, et al.: Efficacy of gabapentin in migraine prophylaxis. Headache 2001, 41:119–128. Establishes gabapentin as an agent for migraine preventive therapy.

    Article  PubMed  CAS  Google Scholar 

  25. Storey JR, Calder CS, Hart DE, Potter DL: Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001, 41:968–975. Establishes topiramate as an agent for migraine preventive therapy.

    Article  PubMed  CAS  Google Scholar 

  26. Edwards KR, Glantz MJ, Shea P, et al.: Topiramate for migraine prophylaxis: a double-blind, randomized, placebo-controlled study (abstract). Headache 2000, 40:4607.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Jacobi Medical Center, 1400 Pelham Parkway South, 10462, Bronx, NY, USA

    Jill Corbo MD

Authors
  1. Jill Corbo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corbo, J. The role of anticonvulsants in preventive migraine therapy. Current Science Inc 7, 63–66 (2003). https://doi.org/10.1007/s11916-003-0012-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-003-0012-6

Keywords

Search

Navigation